Work

Idelalisib Monotherapy and Durable Responses in Patients with Relapsed or Refractory Marginal Zone Lymphoma (MZL)

Year: 2015

Type: article

Source: Blood

DOI: 10.1182/blood.v126.23.1543.1543

Authors: Peter Martin, Armando Armas, Ajay K Gopal, Emmanuel Gyan, Nina D. Wagner-Johnston, Jan Walewski, Steve Abella, Wei Ye, Betsy Philip, Bess Sorenson, Sven de Vos

Institutions: Weill Cornell Medicine, University of Washington, Centre Hospitalier Universitaire de Tours, Washington University in St. Louis, The Maria Sklodowska-Curie National Research Institute of Oncology, Gilead Sciences (United States), University of California, Los Angeles

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2522786622

FWCI: 2.178

Cites:

Cited by: 18

Related to: 10